Table 1 Clinicopathological characteristics of 106 patients with ICC enrolled in the study
From: Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
| Clinicopathological Characteristics | Value (%) |
|---|---|
| Median age (years) | 60.0 (range, 35–82 years) |
| Gender | |
| Male | 62 (58.5%) |
| Female | 44 (41.5%) |
| HBV infection | |
| Absent | 64 (60.4%) |
| Present | 42 (39.6%) |
| Preoperative AFP (μg/l) | |
| < 9 | 78 (73.6%) |
| ≥ 9 | 28 (26.4%) |
| Preoperative CA19–9 (U/ml) | |
| < 35 | 33 (31.1%) |
| ≥ 35 | 73 (68.9%) |
| Tumor size (mm) | |
| < 50 | 45 (42.5%) |
| ≥ 50 | 61 (57.5%) |
| Tumor number | |
| Single | 89 (84.0%) |
| Multiple | 17 (16.0%) |
| Vascular invasion | |
| Absent | 78 (73.6%) |
| Present | 28 (26.4%) |
| Lymph node metastasis | |
| Absent | 58 (54.7%) |
| Present | 48 (45.3%) |
| Histologic differentiation | |
| Well or moderate | 52 (49.1%) |
| Poor | 54 (50.9%) |
| Distribution | |
| Unilobar | 41 (38.7%) |
| Bilobar | 65 (61.3%) |
| Perineural sheath infiltration | |
| Absent | 92 (86.8%) |
| Present | 14 (13.2%) |
| TNM stage | |
| I | 33 (31.1%) |
| II | 15 (14.2%) |
| III | 10 (9.4%) |
| IV | 48 (45.3%) |
| Tumor recurrence | |
| Absent | 34 (32.1%) |
| Present | 72 (67.9%) |